查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466500

數位治療市場：按組成部分、按應用分類 - 2024-2030 年全球預測

Digital Therapeutics Market by Component (Devices, Software & Services), Application (Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年數位治療市場規模為64.2億美元，預計2024年將達80.5億美元，2030年將達331.6億美元，複合年成長率為26.42%。

數位治療，縮寫為 DTx，是指數位健康的一個分支，涵蓋旨在預防、管理和治療醫學病症和疾病的軟體主導的治療性介入。數位療法是根據臨床證據開發的，並且通常經過嚴格的監管審查。數位療法旨在單獨使用或與傳統療法結合使用，為患者、醫療保健提供者和付款人提供資料主導的解決方案，以改善患者護理和健康結果。隨著慢性病變得更加嚴重、醫療成本上升以及醫療保健技術進步，數位治療市場正在不斷成長。智慧型手機的普及和遠端醫療服務的接受也促進了這項技術的採用。對個人化預防保健解決方案的需求進一步推動了市場成長。然而，市場面臨相當大的挑戰，包括監管障礙、對患者資料安全的擔憂以及數位治療應用的臨床檢驗需求。面對這些挑戰，數位治療和電子健康記錄(EHR) 的整合、人工智慧和機器學習的潛力，為數位治療市場的創新和未來成長鋪平了道路。

主要市場統計
基準年[2023] 64.2億美元
預測年份 [2024] 80.5億美元
預測年份 [2030] 331.6億美元
複合年成長率（%） 26.42%

組件資料分析軟體和合規服務的重要性日益增加

數位治療中包含的設備通常是穿戴式裝置、感測器和其他類型的收集患者資料的生物醫學硬體。這些設備可以追蹤各種健康指標，包括身體活動、睡眠模式和血糖值。偏好傾向於易用性、準確性以及與軟體應用程式的無縫整合。軟體和服務被認為是數位療法的核心。此部分由提供治療性介入的平台、應用程式和專業服務組成。軟體和服務的擴充性、互通性、病人參與和資料安全是優先考慮的事項。

應用：數位療法在需要持續管理和監測的糖尿病和慢性呼吸道疾病的採用率很高。

心血管疾病的數位治療解決方案通常包括監測心率、血壓和心血管健康相關習慣的應用程式。有心臟病史或因遺傳因素或生活方式而面臨風險的患者對這些解決方案的需求很高。中樞神經系統疾病應用部分包括帕金森氏症、阿茲海默症、憂鬱症和過動症等疾病的數位療法。 DTx 解決方案旨在認知復健、行為治療和藥物管理。在那些尋求非藥物干預措施的人中，基於需求的偏好尤其強烈。慢性呼吸道疾病的數位療法為氣喘和慢性阻塞性肺病的管理提供了工具，包括吸入器追蹤、症狀追蹤和環境觸發警報。這些是需要持續監測或想要控制疾病惡化的患者的首選。糖尿病數位解決方案專注於血糖值監測、胰島素劑量追蹤和生活方式指導。由於日常管理和監測的需要，糖尿病管理應用程式受到高度青睞。 DTx 的藥物依從性應用程式旨在解決患者不按處方服藥的挑戰。儘管這種需求對於所有患者類別來說都是通用的，但它在慢性病的管理中尤其重要。針對肌肉骨骼疾病的數位療法提供運動計畫、疼痛管理技術和物理治療指導。它是尋求傳統治療替代或補充治療的患者的首選。肥胖的數位治療策略包括個人化營養、身體活動追蹤和行為矯正計劃。全球肥胖率上升和相關健康風險推動了這一領域的需求。糖尿病前期的數位療法著重於生活方式干涉，以預防第 2 型糖尿病的發展。這些應用對於被診斷患有糖尿病前期的個體來說非常有用，可以減緩或預防疾病進展。戒菸的數位療法包括戒菸計畫、進展追蹤和諮詢援助。這些工具在試圖戒菸的人中很受歡迎，通常是尼古丁替代療法的補充。

區域洞察

在美洲，數位治療市場十分強勁，這得益於先進的法律規範、創業投資的大量投資以及 DTx 公司與醫療保健提供者之間不斷成長的合作夥伴關係。美國食品藥物管理局(FDA) 正在透過處方 DTx 的明確指導和核准為 DTx 產品創造有利的環境，這是將這些解決方案整合到標準醫療保健實踐中的重要一步。歐洲市場格局是由多元化的醫療保健格局推動的，強調基於證據的解決方案，並且各國採用不同的方法將 DTx 整合到其醫療保健系統中。德國的數位醫療法案 (DVG) 等舉措允許醫生開立數位健康應用程式，是支持性法規環境的一個例子。中東和非洲預計將出現成長，儘管仍處於起步階段，主要受到基於行動的醫療保健舉措和旨在改善醫療保健服務可近性的合作夥伴關係的推動。亞太地區具有不同的經濟、文化和技術準備度，在數位治療方面展現出巨大的潛力。日本和新加坡等國家處於 DTx 採用的前沿，並在數位醫療創新方面擁有有利的監管途徑和措施。在印度和中國等其他地區，智慧型手機普及的不斷提高以及政府支持數位健康生態系統的努力正在為 DTx 的擴張創造機會。

FPNV定位矩陣

FPNV 定位矩陣對於評估數位治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對數位治療市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 數位治療市場的市場規模和預測是多少？

2.數位治療市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3. 數位治療市場的技術趨勢和法規結構是什麼？

4.數位治療市場主要廠商的市場佔有率是多少？

5. 進入數位治療市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和生活方式相關健康問題的發生率增加
      • 政府推動遠端醫療和遠距醫療的舉措
      • 結合醫療保健應用程式部署智慧型手機和平板電腦
    • 抑制因素
      • 新興經濟體對數位療法的認知較低
    • 機會
      • 數位治療中計算與人工智慧的出現
      • 增加對數位健康業務的資金和投資
    • 任務
      • 資料隱私和安全問題
  • 市場區隔分析
    • 組成部分：資料分析軟體和合規服務的重要性日益增加
    • 應用：提高糖尿病和慢性呼吸道疾病數位療法的採用率，需要持續管理和監控
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章數位治療市場：按組成部分

  • 裝置
  • 軟體和服務

第7章數位治療市場：依應用分類

  • 循環系統疾病
  • 中樞神經系統疾病
  • 慢性呼吸道疾病
  • 糖尿病
  • 用藥依從性
  • 肌肉骨骼疾病
  • 肥胖
  • 糖尿病前期
  • 禁止抽煙

第8章美洲數位治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太數位治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的數位治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • BehaVR 與 Fern Health 合併成立 RealizedCare，推出數位護理管理平台，釋放數位治療的價值
    • Better Therapeutics 宣布推出 AspyreRxTM 治療成年第 2 型糖尿病患者
    • Lumanity 加入數位治療聯盟
  • 戰略分析和建議

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-431752EA4722

[194 Pages Report] The Digital Therapeutics Market size was estimated at USD 6.42 billion in 2023 and expected to reach USD 8.05 billion in 2024, at a CAGR 26.42% to reach USD 33.16 billion by 2030.

Digital therapeutics, abbreviated as DTx, refers to a branch of digital health that encompasses a range of software-driven therapeutic interventions designed to prevent, manage, or treat a medical disorder or disease. Digital therapeutics are developed on the basis of clinical evidence and often undergo rigorous regulatory review. They are intended to be used independently or in conjunction with traditional medical treatments, and they provide patients, healthcare providers, and payers with data-driven, personalized approaches to enhance patient care and health outcomes. The digital therapeutics market is growing with the escalation of chronic diseases, rising healthcare costs, and advancements in healthcare technologies. Increasing smartphone penetration and the acceptance of telehealth services also contribute to the adoption of this technology. The demand for personalized and preventive healthcare solutions further strengthens the market's progress. However, the market faces considerable challenges, including regulatory hurdles, patient data security concerns, and the need for clinical validation of digital therapeutic applications. Amidst these challenges, the integration of digital therapeutics with electronic health records (EHRs) and the potential of AI and machine learning pave the way for innovation and the future growth of the digital therapeutics market.

KEY MARKET STATISTICS
Base Year [2023] USD 6.42 billion
Estimated Year [2024] USD 8.05 billion
Forecast Year [2030] USD 33.16 billion
CAGR (%) 26.42%

Component: Growing significance of data analysis software and compliance services

Devices in digital therapeutics are often wearables, sensors, and other types of biomedical hardware that collect patient data. These devices can track a wide array of health metrics, such as physical activity, sleep patterns, and blood glucose levels. Need-based preference in devices leans towards user-friendliness, accuracy, and seamless integration with software applications. Software & services are seen as the core of digital therapeutics. This segment consists of platforms, applications, and professional services that deliver therapeutic interventions. Preference is given to scalability, interoperability, patient engagement, and data security of software and services.

Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring

Digital therapeutic solutions aimed at cardiovascular diseases often include applications that monitor heart rate, blood pressure, and cardiovascular health-related habits. Need-based preference for these solutions is high among patients with a history of heart disease and those at risk due to genetic factors or lifestyle. The central nervous system disorder application segment includes digital therapeutics for diseases including Parkinson's, Alzheimer's, depression, and ADHD. DTx solutions here aim at cognitive rehabilitation, behavior therapy, and medication management. Need-based preference is particularly strong among individuals seeking non-pharmacological interventions. Digital therapeutics in chronic respiratory diseases offer tools for asthma and COPD management, including inhaler tracking, symptom tracking, and environmental trigger alerts. These are preferred by patients needing continuous monitoring and those looking to manage disease exacerbations. Digital solutions for diabetes focus on blood glucose monitoring, insulin dosage tracking, and lifestyle coaching. Preference for diabetes management apps is high owing to the need for daily management and monitoring. Medication adherence applications of DTx aim to tackle the challenge of patients not taking their medications as prescribed. This need is ubiquitous across all patient categories but is particularly critical in the management of chronic diseases. Digital therapeutics for musculoskeletal disorders offer exercise programs, pain management techniques, and physical therapy guidance. They are highly preferred by patients seeking remote or supplemental treatment to traditional therapy. Digital therapeutic strategies for obesity include personalized nutrition, physical activity tracking, and behavior modification programs. The need in this segment is driven by the global rise in obesity rates and the associated health risks. Digital therapeutics for prediabetes focus on lifestyle interventions to prevent the onset of type 2 diabetes. These applications are useful for individuals identified as having prediabetes to delay or prevent disease progression. For smoking cessation, digital therapeutics include quit plans, tracking of progress, and counseling support. These tools have a high preference among those trying to quit smoking, often complementing nicotine replacement therapies.

Regional Insights

In the Americas, the market for digital therapeutics is robust, underpinned by progressive regulatory frameworks, significant venture capital investments, and growing partnerships between DTx companies and healthcare providers. The United States Food and Drug Administration (FDA) has been creating a conducive environment for DTx products through clear guidance and approvals for prescription DTx, which are seen as important steps toward integrating these solutions into standard healthcare practices. Europe's digital therapeutics market is marked by a strong emphasis on evidence-based solutions and is driven by a diverse healthcare landscape where countries are adopting various approaches to integrate DTx into their healthcare systems. Initiatives such as Germany's Digital Healthcare Act (DVG), which allows doctors to prescribe digital health applications, exemplify the supportive regulatory environment. The Middle East and Africa, while still at nascent stages, are expected to witness growth, largely propelled by mobile-based health initiatives and partnerships aiming to improve access to healthcare services. The APAC region shows vast potential for digital therapeutics, although the market presents a heterogeneous mix of economic, cultural, and technological readiness. Countries, including Japan and Singapore, are at the forefront of adopting DTx, with favorable regulatory pathways and initiatives for digital health innovation. In other areas, such as India and China, rising smartphone penetration and government initiatives to support digital health ecosystems are creating opportunities for DTx expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Digital Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Digital Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 2morrow Inc., Akili Interactive Labs, Inc., Ayogo Health Inc., Better Therapeutics, Inc., Big Health, Inc., Biofourmis Inc., Canary Health Technologies Inc., Click Therapeutics, Inc., Cognoa, Inc., DarioHealth Corp., Fern Health, Inc., Fitterfly Healthtech Private Limited, Happify, Inc., Headspace Inc., Kaia Health Software Inc., Lark Technologies, Inc., Lumanity Inc., MedRhythms, Noom, Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health by ResMed Corp., SilverCloud by American Well Corporation, Voluntis by AptarGroup, Inc., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Devices
    • Software & Services
  • Application
    • Cardiovascular Disease
    • Central Nervous System Disorder
    • Chronic Respiratory Disease
    • Diabetes
    • Medication Adherence
    • Musculoskeletal Disorder
    • Obesity
    • Prediabetes
    • Smoking Cessation
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Digital Therapeutics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital Therapeutics Market?

3. What are the technology trends and regulatory frameworks in the Digital Therapeutics Market?

4. What is the market share of the leading vendors in the Digital Therapeutics Market?

5. Which modes and strategic moves are suitable for entering the Digital Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of chronic diseases and lifestyle-related health issues
      • 5.1.1.2. Government initiatives promoting telehealth and telemedicine
      • 5.1.1.3. Adoption of smartphones and tablets coupled with healthcare apps
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness regarding digital therapeutics in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advent of computing and artificial intelligence in digital therapeutics
      • 5.1.3.2. Rising funding and investments for digital health businesses
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Growing significance of data analysis software and compliance services
    • 5.2.2. Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Digital Therapeutics Market, by Component

  • 6.1. Introduction
  • 6.2. Devices
  • 6.3. Software & Services

7. Digital Therapeutics Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Central Nervous System Disorder
  • 7.4. Chronic Respiratory Disease
  • 7.5. Diabetes
  • 7.6. Medication Adherence
  • 7.7. Musculoskeletal Disorder
  • 7.8. Obesity
  • 7.9. Prediabetes
  • 7.10. Smoking Cessation

8. Americas Digital Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
    • 11.3.2. Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
    • 11.3.3. Lumanity Joins The Digital Therapeutics Alliance
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DIGITAL THERAPEUTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 52. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 56. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 68. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 72. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 73. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 76. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 77. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 80. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 81. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 84. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 85. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 88. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 96. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 97. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 100. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 104. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 105. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 108. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 109. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 112. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 113. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 122. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 123. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 126. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 127. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 130. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 131. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 134. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 135. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 138. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 139. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 142. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 143. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 146. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 147. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 150. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 151. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 154. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 155. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 158. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 159. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 162. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 163. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 166. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 167. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 170. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 171. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 174. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 175. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 182. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 183. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 186. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 187. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 190. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 191. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 194. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 195. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 199. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 202. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 206. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023